
Company Info
Year Established2025
Contacts
Stephen SmithFounder & CEO
Company Description
Q-immune is building the critical "bench to bedside to bench" validation loop that combines high-throughput multiplex proteomics and AI to unlock a therapy’s functional blueprint, moving beyond traditional assays to capture the dynamic signaling networks that predict a therapy’s safety and efficacy.